MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Pilot trial of botulinum toxin and occupational therapy for Writer’s Cramp

J. Park, E. Shamim, O. Panyakaew, P. Mathew, C. Toro, J. Sackett, B. Karp, C. Lungu, K. Alter, B. Hodsdon, M. Villegas, T. Wu, O. Ahmad, P. Srivanitchapoom, S. Auh, M. (Goyang, Republic of Korea)

Meeting: 2018 International Congress

Abstract Number: 744

Keywords: Dystonia: Clinical features, Dystonia: Treatment

Session Information

Date: Sunday, October 7, 2018

Session Title: Dystonia

Session Time: 1:45pm-3:15pm

Location: Hall 3FG

Objective: We aimed to compare the effects of botulinum toxin (BoNT) therapy alone with a combination of BoNT and occupational therapy on patients with writer’s cramp as measured by a patient-rated subjective scale.

Background: Writer’s cramp (WC) is a form of focal hand dystonia, for which focal BoNT injections are the current best therapy. Past studies have shown that some types of rehabilitative therapy can be useful. We hypothesized that BoNT together with a specific type of occupational therapy would be better than BoNT alone for treating patients with WC.

Methods: Twelve WC patients were randomized to two groups. 6 patients received only BoNT therapy and 6 patients received BoNT therapy and occupational therapy. The occupational therapy involved specific exercises of finger movements in the direction opposite to the patient’s dystonic movements during the writing task. Therapy was performed with splints made to suit the individual patient. The primary outcome was the patient-rated subjective scale at 20 weeks. Secondary, exploratory outcomes were assessed by four blinded raters of the videotapes via several scales, including the writer’s cramp rating scale (WCRS), writer’s cramp impairment scale (WCIS), and the writer’s cramp disability scale (WCDS). Writing parameters obtained via handwriting analysis program were also analyzed.

Results: The patient-rated subjective scale scores at 20 weeks were not significantly different between the two treatment groups. WCIS and WCRS scores (27% and 18%, respectively) were significantly improved with combination therapy compared with BoNT alone.

Conclusions: The study was powered on the expected effect size of the primary outcome measure of subjective improvement; this was not achieved. However, the secondary measures were suggestive indicating a major limitation of sample size. Therefore, further study of occupational therapy methods to improve the efficacy of BoNT seem worthwhile.

References: 1. How to assess motor impairment in writer’s cramp. Zeuner KE1, Peller M, Knutzen A, Holler I, Münchau A, Hallett M, Deuschl G, Siebner HR. Mov Disord. 2007 Jun 15;22(8):1102-9. 2. Botulinum toxin in writer’s cramp: objective response evaluation in 31 patients. Wissel, J., et al. (1996). J Neurol Neurosurg Psychiatry 61(2): 172-175.

To cite this abstract in AMA style:

J. Park, E. Shamim, O. Panyakaew, P. Mathew, C. Toro, J. Sackett, B. Karp, C. Lungu, K. Alter, B. Hodsdon, M. Villegas, T. Wu, O. Ahmad, P. Srivanitchapoom, S. Auh, M.. Pilot trial of botulinum toxin and occupational therapy for Writer’s Cramp [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/pilot-trial-of-botulinum-toxin-and-occupational-therapy-for-writers-cramp/. Accessed May 9, 2025.
  • Tweet
  • Email
  • Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/pilot-trial-of-botulinum-toxin-and-occupational-therapy-for-writers-cramp/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley